Kelly Pittman

1.7k citations
57 papers · 1.4k indexed · h-index 22
Topics
Antibiotics Pharmacokinetics and Efficacy (26 papers)Analytical Methods in Pharmaceuticals (10 papers)Drug Transport and Resistance Mechanisms (9 papers)

In The Last Decade

Kelly Pittman

56 papers receiving 1.3k citations

Peers

Kelly Pittman
Comparison fields: 5 of 112
  • Pharmacology 678
  • Molecular Medicine 317
  • Epidemiology 218
  • Molecular Biology 193
  • Oncology 168
Replace Céline M. Laffont with:
Céline M. Laffont France
Allen H. Heller United States
José Ramón Azanza Perea Spain
Michael S. Schwartz United States
Jan Van Bocxlaer Belgium
Tom B. Vree Netherlands
Olivier Petitjean France
H Laufen Germany
David P. Benziger United States
Elwood L. Foltz United States
Kelly Pittman relative to Céline M. Laffont France Céline M. Laffont's profile →
Citations per field
00.5×4.3×
Céline M. Laffont · 1×
Citations per year

Countries citing papers authored by Kelly Pittman

Since Specialization
Citations

This map shows the geographic impact of Kelly Pittman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kelly Pittman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kelly Pittman more than expected).

Fields of papers citing papers by Kelly Pittman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kelly Pittman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kelly Pittman. The network helps show where Kelly Pittman may publish in the future.

Co-authorship network of co-authors of Kelly Pittman

This figure shows the co-authorship network connecting the top 25 collaborators of Kelly Pittman. A scholar is included among the top collaborators of Kelly Pittman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kelly Pittman. Kelly Pittman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1
The primacy of humoral antibody (complement-dependent cytotoxicity and antibody-dependent cellular cytotoxicity) in concordant xenograft rejection.
2
2 21
3 21
4 16
5 26
6 28
7 10
8 7
9
15-Deoxyspergualin produces inhibition of lymphokine-activated killer cell activity.
2
10 52
11 13
12 5
13 45
14 22
15 2
16 86
17 8
18 37
19
Stabilization and preservation of hepatic drug metabolizing systems
9
20 34

About Kelly Pittman

Kelly Pittman is a scholar working on Applied Microbiology and Biotechnology, Pharmacology and Pharmacology, having authored 57 papers that have together received 1.4k indexed citations. Recurring topics across this work include Antibiotics Pharmacokinetics and Efficacy (26 papers), Analytical Methods in Pharmaceuticals (10 papers) and Drug Transport and Resistance Mechanisms (9 papers). The work is most often cited by research in Molecular Medicine (317 citations), Applied Microbiology and Biotechnology (86 citations) and Pharmacology (678 citations). Kelly Pittman has collaborated with scholars based in United States, Germany and United Kingdom. Frequent co-authors include Rashmi H. Barbhaiya, Wen Chyi Shyu, M. P. Bryant, C A Knupp, Carol Gleason, S. Thomas Forgue, Umesh Shukla, R. Russell Martin, Richard B. Wilber and Raymond H. Farmen. Their work appears in journals such as Journal of Agricultural and Food Chemistry, Journal of Bacteriology and The Journal of Infectious Diseases.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026